Core Biogenesis specializes in the production of plant-derived recombinant proteins, focusing on applications in life sciences and skincare. Their flagship products include a range of recombinant growth factors, such as FGF-2 TOP® (Thermostable), recombinant human FGF-2, and recombinant IGF-1 LR3. These growth factors are designed to enhance cell culture processes, including 3D, large-scale, and suspension cell cultures. The company emphasizes the importance of using animal-free, endotoxin-free, and biorisk-free recombinant growth factors, which are crucial for maintaining the consistency and reproducibility of cell cultures, particularly in stem cell research and regenerative medicine.

Core Biogenesis employs proprietary technologies to optimize the production and purification of recombinant proteins. Their innovative yield-boosting technology streamlines the mass production process, making it more efficient and cost-effective. Additionally, their proprietary extraction methods allow for the isolation of molecules from specific plant compartments, enhancing scalability and reducing costs. This approach not only supports the development of high-performance recombinant molecules but also contributes to a more sustainable future in bioproduction. The company’s commitment to quality and innovation positions it as a key player in the field of cell-based applications and therapies.

France

Core Biogenesis

Company Details